全球促肾上腺皮质激素 (ACTH) 市场 – 行业趋势和 2029 年预测

 市场分析和规模

近年来，促肾上腺皮质激素 (ACTH) 市场预计在预测期内将快速增长。COVID-19 疫情由整个美国医疗保健系统管理，该系统正在规划、准备和合作。促肾上腺皮质激素 (ACTH) 行业的制造商正试图了解高危患者和呼吸系统疾病患者的护理习惯，以维持连续的供应链。制造商正在与紧急护理中心、药店的零售诊所和工作场所诊所建立稳固的供应链，以在疫情期间保持经济运转。由于急诊室已经不堪重负，这些地方可以像湿地一样运作，吸收一些患病和健康患者的溢出量。

Data Bridge Market Research 分析，促肾上腺皮质激素 (ACTH) 市场在 2021 年的价值为 13.8 亿美元，预计到 2029 年将达到 22 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 6.00%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

脑垂体是大脑底部附近的一个小腺体，它会产生促肾上腺皮质激素 (ACTH)?。促肾上腺皮质激素 (ACTH)? 调节另一种激素皮质醇的产生。肾上腺是位于肾脏上方的两个小腺体，它会产生皮质醇。

报告范围和市场细分

Adrenocorticotropic Hormone (ACTH)? Market Dynamics

Drivers

• Rise in the use of adrenocorticotropic hormone (ACTH) products

Over the last few years, the use of adrenocorticotropic hormone (ACTH) has expanded dramatically. The adrenocorticotropic hormone is currently used to treat nephrotic syndrome, ophthalmology, rheumatology, Addison disease, Cushing syndrome, and Cushing illness, among other conditions. The increased use of adrenocorticotropic hormone (ACTH) products produces a tremendous demand for these goods and acts as a market driver.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of adrenocorticotropic hormone (ACTH)? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the adrenocorticotropic hormone (ACTH)? market. Additionally, high disposable income and surging prevalence of multiple sclerosis and infantile spasms will expand the adrenocorticotropic hormone (ACTH)? market. Along with this, rising incidences of stress and anxiety among people and favourable reimbursement policies will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth. Rising approvals and launches with adrenocorticotropic hormone (ACTH) will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the adrenocorticotropic hormone (ACTH)? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the adrenocorticotropic hormone (ACTH)? market. Additionally, side effects of adrenocorticotropic hormone (ACTH)? and lack of awareness will act as market restraints and further impede the market's growth rate during the forecast period of 2022-2029.

This adrenocorticotropic hormone (ACTH)? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenocorticotropic hormone (ACTH)? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Adrenocorticotropic hormone (ACTH)? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Adrenocorticotropic Hormone (ACTH)? Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The inkjet printers market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the adrenocorticotropic hormone (ACTH) market's revenue trajectory.

Global Adrenocorticotropic Hormone (ACTH)? Market Scope

促肾上腺皮质激素 (ACTH) 市场根据来源、应用、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

来源

• 自然的
• 合成的

根据来源，全球促肾上腺皮质激素 (ACTH) 市场分为天然和合成。

应用

• 风湿病学
• 神经病学
• 肾病综合征
• 眼科
• 其他的

根据应用，全球促肾上腺皮质激素 (ACTH) 市场分为风湿病学、神经病学、肾病综合征、眼科学和其他。

最终用户

• 医院
• 专科诊所
• 家庭护理
• 其他的

根据最终用户，促肾上腺皮质激素 (ACTH) 市场分为医院、专科诊所、家庭护理和其他。

分销渠道

• 医院药房
• 零售药店
• 网上药店
• 其他的

根据分销渠道，促肾上腺皮质激素 (ACTH) 市场也细分为医院药房、零售药房、网上药房和其他。

促肾上腺皮质激素 (ACTH) ?市场区域分析/见解

对促肾上腺皮质激素 (ACTH) 市场进行了分析，并按国家、来源、应用、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。

促肾上腺皮质激素 (ACTH) 市场报告涵盖的国家有：北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 其他地区、巴西、阿根廷以及南美洲其他地区

北美主导促肾上腺皮质激素 (ACTH) 市场，因为该地区的研发活动数量不断增加。此外，主要关键参与者的不断增加将进一步推动该地区市场的增长率。

由于医疗保健支出不断增加且政府加大力度改善医疗保健基础设施，预计亚太地区在 2022 年至 2029 年的预测期内将实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和促肾上腺皮质激素 (ACTH) ？市场份额分析

促肾上腺皮质激素 (ACTH) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对促肾上腺皮质激素 (ACTH) 市场的关注有关。

促肾上腺皮质激素 (ACTH) 市场的一些主要参与者包括：

• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 默克公司（美国）
• 诺华公司（瑞士）
• Hikma Pharmaceuticals PLC（英国）
• Avantor, Inc.（美国）
• Ferring BV（瑞士）
• Viatris, Inc.（美国）
• 默克集团（德国）

SKU-68078